| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080053 treatment of RNA viral infections such as HCV, HBV, small pox, Ebola, polio, West Nile, Coxsackie A and B, Rhino, and Echo viral infection; viricides |
| 04/14/2005 | US20050080050 Lipid analogs for treating viral infections |
| 04/14/2005 | US20050080047 Chiral diphosphorus compounds and their transition metal complexes |
| 04/14/2005 | US20050079290 a tantalum complex recursor for a barrier layer selected from tantalum nitride, tantalum oxide or bismuth tantalum oxide |
| 04/14/2005 | DE10392453T5 Metallkomplex und organische elektrolumineszierende Vorrichtung Metal complex, and organic electroluminescent device |
| 04/14/2005 | CA2821433A1 Lpa receptor agonists and antagonists and methods of use |
| 04/14/2005 | CA2540809A1 Lpa receptor agonists and antagonists and methods of use |
| 04/13/2005 | EP1521738A2 Method for making nitrile compounds from ethylenically unsaturated compounds |
| 04/13/2005 | EP1521736A1 Making nitrile compounds from ethylenically unsaturated compounds |
| 04/13/2005 | EP1401845B1 Method for producing n-phosphonomethylglycine |
| 04/13/2005 | EP1399465B1 Ligation method and reagents to form an amide bond |
| 04/13/2005 | EP1268498B1 Cardioprotective phosphonates |
| 04/13/2005 | EP1244641B1 Thiazolyl amide derivatives |
| 04/13/2005 | EP1015469B1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 04/13/2005 | CN1606815A Polymer electrolyte and the use thereof in galvanic cells |
| 04/13/2005 | CN1606592A Novel flame retarding compounds |
| 04/13/2005 | CN1606539A Trimerisation and oligomerisation of olefins using a chromium based catalyst |
| 04/13/2005 | CN1606538A Trimerisation and oligomerisation of olefins using a chromium based catalyst |
| 04/13/2005 | CN1606431A Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 04/13/2005 | CN1605588A Chloro- hydroxy- monocrotophos and its preparation and use |
| 04/13/2005 | CN1196701C Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of 1-3-oxaselenolane nucleosides |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/12/2005 | US6878846 Reacting a carbonyl compound with a phosphorus halide in a carrier/solvent system (which consists of an amine hydrochloride, a phosphorus acid) to produce a bisphosphonate |
| 04/12/2005 | US6878831 Optical resolution |
| 04/12/2005 | US6878723 Carbocyclic and/or heterocyclic amino carboxylic acids, e.g., 2-aminomethyl-6-(p-benzylphenoxy)hexanoic acid; leukotriene A4 hydrolase; treating arthritis and psoriasis; hematoprotective and antimitotic agents |
| 04/12/2005 | US6878708 Imidazotriazinones and the use thereof |
| 04/12/2005 | US6878697 Containing one or more phosphorus-containing moieties; treating bone disorders |
| 04/12/2005 | US6878690 Compounds and methods |
| 04/12/2005 | US6878665 Diphosphines, their complexes with transisition metals and their use in asymmetric synthesis |
| 04/12/2005 | CA2174107C Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| 04/07/2005 | WO2005030799A1 Antisense compound and method for selectively killing activated t cells |
| 04/07/2005 | WO2005030781A1 Process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives |
| 04/07/2005 | WO2005030780A1 Fluorescent labeled sphingosines |
| 04/07/2005 | WO2005009934A3 Two-stage hydroformylation |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | US20050075516 Anticarcinogenic agents formed by phosphorylation |
| 04/07/2005 | US20050075511 Prevention of human and/or animal viral, bacterial, fungal or parasitic infections; plant fungicides, bactericides and/or herbicides; reduced side effects; environmentally friendly; such as ((n-formyl-n-hydroxyamino)-methoxy)-methyl phosphonic acid disodium salt |
| 04/07/2005 | US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals |
| 04/07/2005 | US20050075337 Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease |
| 04/07/2005 | US20050075318 Antiviral for RNA or DNA viruses such as HIV, HBV or HSV; acyclic pyrimidine nucleoside phosphonate analogues; 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidine; ; alkylating the 6-hydroxypyrimidine base with a dialkyl 2-chloroethoxymethylphosphonate |
| 04/07/2005 | US20050075317 Monitoring the protein concentration in plasma or tissues; treating atherosclerosis, Alzheimer's disease, macular degeneration, retinitis pigmentosa, stroke, degenerative neuropathy, multiple sclerosis, xanthoma, xanthelasma, cardiovascular disorder; tetramethyl N-(2-pyridyl)aminomethylenediphosphonate |
| 04/07/2005 | US20050075316 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmai agents; anticancer agents; astaxanthin |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | US20050074470 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 04/07/2005 | US20050072686 electrochemical reactions; safe, in situ, controlled generation of high energy reactants |
| 04/07/2005 | CA2539972A1 Antisense compound and method for selectively killing activated t cells |
| 04/06/2005 | EP1520857A1 Process for the preparation of N-(phosphonomethyl) glycine by oxidizing N-substituted N-(phosphonomethyl) glycine |
| 04/06/2005 | EP1519937A1 Process and intermediates for making non-nucleoside hiv-1 reverse transcriptase inhibitors |
| 04/06/2005 | EP1239957B1 Double metal cyanide catalysts for producing polyether polyols |
| 04/06/2005 | EP1089818B1 Catalyst comprising a complex of a metal of group viii and a phosphinite ligand, and a method for hydroformylation |
| 04/06/2005 | EP1001928B1 Improved hydrocyanation process |
| 04/06/2005 | CN1604904A Phosphonic acid compounds as inhibitors of serine proteases |
| 04/06/2005 | CN1603331A 9-{2-[bis(pivaloyloxymethoxy) phosphorylmethoxyl]ethyl} adenine glucuronate and its preparation process |
| 04/06/2005 | CN1603327A New process for the preparation of vinyl pyrrolidinone cephalosporine derivatives |
| 04/06/2005 | CN1195783C Polymerization of olefins |
| 04/06/2005 | CN1195766C Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same |
| 04/06/2005 | CN1195764C Transition metal complex, preparation method and use thereof |
| 04/06/2005 | CN1195763C Method for preparing N-phosphono-methyl glycosine |
| 04/06/2005 | CN1195748C 1, 2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/05/2005 | US6875886 Modified PSMA ligands and uses related thereto |
| 04/05/2005 | US6875859 Heterocyclic compounds and their use in the detection of nucleic acids |
| 04/05/2005 | US6875831 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 04/05/2005 | US6875757 LPA receptor agonists and antagonists and methods of use |
| 04/05/2005 | US6875718 Benzeneoxyimine transition metal compound, an organometallic compound, an oranoaluminum oxy-compound or an ionizing ionic compound |
| 04/05/2005 | US6875523 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 04/05/2005 | CA2166975C Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | WO2005028488A1 Heteroaryl phosphinyl and thiophosphinyl compounds for regulation of glucose, triglycerides, and ldl/hdl levels |
| 03/31/2005 | WO2005028487A1 Process for recovering a crystalline product from solution |
| 03/31/2005 | WO2005028478A1 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 03/31/2005 | WO2005028434A2 Novel heterocyclic compounds as hsp90-inhibitors |
| 03/31/2005 | WO2005028411A1 Bipolar trans carotenoid salts and their uses |
| 03/31/2005 | WO2005027934A1 Prolyl oligopeptidase inhibitor |
| 03/31/2005 | WO2005014581A3 Lanthanide complexes preparation and uses thereof |
| 03/31/2005 | WO2005007634A8 3-hydroxy-4-oxo-1,2,3-triazines and derivatives thereof for amide and ester bond formation |
| 03/31/2005 | WO2004111063A3 Chiral ligands for application in asymmetric syntheses |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | WO2004092139A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 03/31/2005 | WO2004037161A3 Cyclic prodrugs of pmea one of its analogues |
| 03/31/2005 | US20050070732 Benzene phosphinic acid with improved flowability |
| 03/31/2005 | US20050070722 Chemical intermediate for cephalosporin bactericides |
| 03/31/2005 | US20050070715 Methods for synthesis of acyloxyalkyl compounds |
| 03/31/2005 | US20050070541 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis |
| 03/31/2005 | US20050070507 Process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives |
| 03/31/2005 | US20050070505 Phosphinic pseudo-peptide derivatives for the selective inhibition of the active c-terminal site of angiotensin converting enzyme (I) (ace) |
| 03/31/2005 | DE10337013A1 New bisarylbisphosphine compounds are used for production of catalysts for asymmetric synthesis |
| 03/31/2005 | CA2539548A1 Novel heterocyclic compounds as hsp90-inhibitors |
| 03/31/2005 | CA2539318A1 Process for recovering a crystalline product from solution |
| 03/31/2005 | CA2537325A1 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 03/31/2005 | CA2537210A1 Bipolar trans carotenoid salts and their uses |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517911A1 Tumour-inhibiting platinum (ii) oxalate complexes |
| 03/30/2005 | EP1517910A1 Phosphoramidites for coupling oligonucleotides to (2 + 2) photoreactive groups |
| 03/30/2005 | EP1517895A1 8-(biaryl) quinoline pde4 inhibitors |
| 03/30/2005 | EP1517891A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof |
| 03/30/2005 | EP1289998B1 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives |
| 03/30/2005 | EP1147100B1 Recovery of chroman derivatives |
| 03/30/2005 | EP1000022B1 Hydrocyanation processes and multidentate phosphite ligand and nickel catalyst compositions therefor |